Next Generation Sequencing Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Next Generation Sequencing Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The overall valuation of the next-generation sequencing sector has seen swift expansion lately, projected to climb from $12.5 billion recorded in 2024 to $14.2 billion the following year, reflecting a compound annual growth rate (CAGR) of 13.6% across this span. This upward trajectory during the past period stemmed from multiple contributing elements, including augmented financial backing, climbing spending within the healthcare domain, the burgeoning expansion of developing economies, swift technological improvements, and the progressively aging demographic worldwide.

The market encompassing next-generation sequencing is projected to achieve substantial expansion in the upcoming years, reaching a valuation of $24.81 billion by 2029, propelled by a steady compound annual growth rate (CAGR) of 15.0%. This upward trajectory through the projection timeframe is underpinned by several key factors, such as the expanding senior demographic, greater availability of healthcare services, a mounting incidence of long-term health conditions, and the heightened necessity for next-generation sequencing prompted by the COVID-19 pandemic. Principal developments anticipated during this forecasting interval involve the emphasis on integrating artificial intelligence to achieve reductions in both expenditure and processing time, the pursuit of economical methodologies for investigating infrequently occurring medical conditions to sustain a competitive advantage against alternative techniques, the provision of NGS solutions specifically for neonatal screening programs, and the implementation of big data technologies for the thorough examination of extensive genomic datasets.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3990&type=smp

Which Factors And Drivers Are Influencing The Next Generation Sequencing Market In 2025?

The expansion within the next-generation sequencing market is substantially driven by the increasing incidence of persistent ailments like cancer, AIDS, and thalassemia. Globally, there is an upward trend in chronic illnesses and disorders, a situation exacerbated by an aging populace and evolving societal patterns, resulting in a steady escalation of these pervasive and costly long-term health challenges. Researchers and medical practitioners find next-generation sequencing (NGS) to be a highly adaptable technological instrument employed throughout numerous cancer investigations to pinpoint crucial biomarkers that inform therapeutic decisions. Furthermore, projections from the World Health Organization anticipate a considerable surge in the frequency of chronic diseases. Consequently, the heightened occurrence of these long-term health issues will inevitably heighten the demand for NGS capabilities, thereby fueling revenue growth within the next-generation sequencing market sector.

What Are The Different Segment Classifications Within The Next Generation Sequencing Market?

The next generation sequencingmarket covered in this report is segmented –

1) By Product: Instruments, Reagents And Kits, Software

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing, Other Sequencing Technologies

3) By Application: Diagnostics, Drug Discovery, Other Applications

Subsegments:

1) By Instruments: Sequencing Systems, Library Preparation Instruments, Quality Control Instruments

2) By Reagents And Kits: Sequencing Reagents, Library Preparation Kits, Amplification Kits

3) By Software: Data Analysis Software, Bioinformatics Software, Workflow Management Software

What Key Innovation Trends Are Fueling Advancements In The Next Generation Sequencing Market?

Leading entities within the next-generation sequencing sector are prioritizing the creation of novel methodologies, notably advanced NGS platform technology, aiming to significantly boost sequencing rapidity, precision, and economic viability; notable breakthroughs encompass better precision levels, increased processing capacity, and the incorporation of artificial intelligence for subsequent data interpretation. These sophisticated NGS systems represent cutting-edge capabilities facilitating swift and economical examination of DNA and RNA by managing vast quantities of fragments concurrently, finding utility across diverse fields such as complete genome mapping and focused resequencing efforts, consequently revolutionizing foundational genomic studies and the practice of individualized healthcare; exemplify of this progress, in April of 2022, the American biotech firm Thermo Fisher Scientific introduced the IonTorrent Genexus Dx Integrated Sequencer, a device allowing for swift, automated NGS procedures within clinical settings, often yielding outcomes within a 24-hour timeframe, whose adaptable and intuitive interface supports both diagnostic applications and research pursuits, thereby propelling efficiency in precision medicine.

Which Key Players Are Driving Competition In The Next Generation Sequencing Market?

Major companies operating in the next generation sequencing market include Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Agilent Technologies, Inc., Pacific Biosciences of California Inc., Oxford Nanopore Technologies, 10x Genomics, Bio-Rad Laboratories, Inc., MGI Tech Co., Ltd., Oxford Gene Technology, Hoffmann-La Roche Ltd, BGI, PerkinElmer Inc., Macrogen Inc., Genotypic Technology Pvt. Ltd., Beijing Genomics Institute, SciGenom Labs Pvt. Ltd (India), Dante Labs, Roche, First Genetics JCS, Helix, Tempus, Massive Bio, Genetricsinc and King Abdullah International Medical Research Center, Inqaba biotec

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

What Are The Key Regional Factors Influencing The Next Generation Sequencing Market Growth?

North America was the largest region in the next generation sequencing market in 2024. Asia-Pacific was the second largest region in the global next generation sequencing market share. The regions covered in the next generation sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Next Generation Sequencing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3990&type=smp

Browse Through More Reports Similar to the Global Next Generation Sequencing Market 2025, By The Business Research Company

Synthetic Biology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

Molecular Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795